| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-10 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-09 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-09 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-09 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-08 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-08 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-08 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-08 |